首页> 美国卫生研究院文献>Cell Death Disease >CDK5-induced p-PPARγ(Ser 112) downregulates GFAP via PPREs in developing rat brain: effect of metal mixture and troglitazone in astrocytes
【2h】

CDK5-induced p-PPARγ(Ser 112) downregulates GFAP via PPREs in developing rat brain: effect of metal mixture and troglitazone in astrocytes

机译:CDK5诱导的p-PPARγ(Ser 112)通过发育中的大鼠大脑中的PPRE下调GFAP:星形胶质细胞中金属混合物和曲格列酮的作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The peroxisome proliferator-activated receptor gamma (PPARγ), a group of ligand-activated transcriptional factors, is expressed in glial fibrillary acidic protein (GFAP)-immunoreactive astrocytes. Here, we investigated the role of PPARγ in regulating GFAP using a mixture of As, Cd and Pb (metal mixture, MM) that induces apoptosis and aberrant morphology in rat brain astrocytes. We observed a phospho PPARγ (serine 112 (S112)) (p-PPARγ (S112))-mediated downregulation of GFAP in the MM-exposed astrocytes. We validated this using pure PPARγ agonist, troglitazone (TZ). As reported with MM, TZ induced astrocyte damage owing to reduced GFAP. In silico analysis in the non-coding region of GFAP gene revealed two PPARγ response elements (PPREs); inverted repeat 10 and direct repeat 1 sequences. Gel shift and chromatin immunoprecipitation assays demonstrated enhancement in binding of p-PPARγ (S112) to the sequences, and luciferase reporter assay revealed strong repression of GFAP via PPREs, in response to both MM and TZ. This indicated that suppression in GFAP indeed occurs through direct regulation of these elements by p-PPARγ (S112). Signaling studies proved that MM, as well as TZ, activated the cyclin-dependent kinase 5 (CDK5) and enhanced its interaction with PPARγ resulting into increased p-PPARγ (S112). The p-CDK5 levels were dependent on proximal activation of extracellular signal-regulated protein kinase 1/2 and downstream Jun N-terminal kinase. Taken together, these results are the first to delineate downregulation of GFAP through genomic and non-genomic signaling of PPARγ. It also brings forth a resemblance of TZ with MM in terms of astrocyte disarray in developing brain.
机译:过氧化物酶体增殖物激活受体γ(PPARγ)是一组配体激活的转录因子,在胶质原纤维酸性蛋白(GFAP)免疫反应性星形胶质细胞中表达。在这里,我们研究了PPARγ在As,Cd和Pb的混合物(金属混合物,MM)中调节GFAP的作用,该混合物可诱导大鼠脑星形胶质细胞凋亡和异常形态。我们观察到磷酸PPARγ(丝氨酸112(S112))(p-PPARγ(S112))介导的MM暴露的星形胶质细胞中GFAP的下调。我们使用纯PPARγ激动剂曲格列酮(TZ)对此进行了验证。如MM所报道,由于GFAP降低,TZ诱导星形胶质细胞损伤。在GFAP基因非编码区的计算机分析中,发现了两个PPARγ反应元件(PPRE)。反向重复序列10和直接重复序列1。凝胶迁移和染色质免疫沉淀测定法显示p-PPARγ(S112)与序列的结合增强,萤光素酶报告基因测定法显示,响应于MM和TZ,通过PPRE强烈抑制了GFAP。这表明,通过p-PPARγ直接调节这些元素确实可以抑制GFAP(S112)。信号研究证明,MM和TZ均可激活细胞周期蛋白依赖性激酶5(CDK5),并增强其与PPARγ的相互作用,从而导致p-PPARγ升高(S112)。 p-CDK5水平取决于细胞外信号调节蛋白激酶1/2和下游Jun N端激酶的近端激活。综上所述,这些结果是第一个通过PPARγ的基因组和非基因组信号转导描述GFAP下调的结果。就发育中的脑星形胶质细胞紊乱而言,它也使TZ与MM相似。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号